News

4 9 Andes Technology Celebrates 20 Years with New Logo and Headquarters Expansion Andes Technology ... The integration allows vision data to be processed directly by Akida without the need for ...
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 2.37% to $477.52 Monday, on what proved to be an all-around dismal trading ...
Top firms are investing in AI by acquiring startups, building custom tools, and embedding generative models into workflows to ...
Shares of Vertex Pharmaceuticals Inc. VRTX slipped ... Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings ...
Coginiti's introduction of a digital twin delivers a real-time model of an enterprise solving the challenges faced with AI ...
In a report released today, Chris Quintero from Morgan Stanley maintained a Buy rating on Vertex (VERX – Research Report), with a price target of $55.00. Discover outperforming stocks and invest ...
Vertex Growth, a subsidiary of Temasek, has invested €10 million in Dolphin Semiconductor, a provider of semiconductor IP solutions. Vertex joins existing investor Jolt Capital, which in 2024 acquired ...
Milesight, a leading provider of innovative IP-based video surveillance solutions, proudly announces the official launch of its cutting-edge PlateXpert Technology - a transformative advancement in the ...
It’s all starting next week when Europeans in the EU block will start receiving in-app notifications and emails explaining the data that Meta wants to use to train Meta AI and “how this will ...
Along with LSR, Vertex is also running a trial of suzetrigine in painful diabetic peripheral neuropathy (DPN), another form of chronic, neuropathic pain. Commenting on the LSR data, principal ...
Vertex has doubled down on cell-based therapies ... of Semma in 2019 – because the FDA wanted to see additional data before allowing the dose to be increased. Vertex' therapy takes the form ...